Woods YL - Search Results

1

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.

Huang X, Wullschleger S, Shpiro N, McGuire VA, Sakamoto K, Woods YL, McBurnie W, Fleming S, Alessi DR. Huang X, et al. Among authors: woods yl. Biochem J. 2008 Jun 1;412(2):211-21. doi: 10.1042/BJ20080557. Biochem J. 2008. PMID: 18387000

2

Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells.

Logie L, Ruiz-Alcaraz AJ, Keane M, Woods YL, Bain J, Marquez R, Alessi DR, Sutherland C. Logie L, et al. Among authors: woods yl. Diabetes. 2007 Sep;56(9):2218-27. doi: 10.2337/db07-0343. Epub 2007 Jun 11. Diabetes. 2007. PMID: 17563061

3

The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.

Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S, Unterman TG, Cohen P. Woods YL, et al. Biochem J. 2001 May 1;355(Pt 3):597-607. doi: 10.1042/bj3550597. Biochem J. 2001. PMID: 11311120 Free PMC article.

4

Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX.

Woods YL, Rena G. Woods YL, et al. Biochem Soc Trans. 2002 Aug;30(4):391-7. doi: 10.1042/bst0300391. Biochem Soc Trans. 2002. PMID: 12196101 Review.

5

The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG. Woods YL, et al. Biochem J. 2001 May 1;355(Pt 3):609-15. doi: 10.1042/bj3550609. Biochem J. 2001. PMID: 11311121 Free PMC article.

6

Exploiting the p53 pathway for cancer diagnosis and therapy.

Woods YL, Lane DP. Woods YL, et al. Hematol J. 2003;4(4):233-47. doi: 10.1038/sj.thj.6200260. Hematol J. 2003. PMID: 12872148 Review.

7

Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states.

Woods YL, Petrie JR, Sutherland C. Woods YL, et al. Endocr Metab Immune Disord Drug Targets. 2009 Jun;9(2):187-98. doi: 10.2174/187153009788452408. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19519467 Review.

8

Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion.

Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR, Cohen P. Rena G, et al. Among authors: woods yl. EMBO J. 2002 May 1;21(9):2263-71. doi: 10.1093/emboj/21.9.2263. EMBO J. 2002. PMID: 11980723 Free PMC article.

9

Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.

Saville MK, Sparks A, Xirodimas DP, Wardrop J, Stevenson LF, Bourdon JC, Woods YL, Lane DP. Saville MK, et al. Among authors: woods yl. J Biol Chem. 2004 Oct 1;279(40):42169-81. doi: 10.1074/jbc.M403362200. Epub 2004 Jul 26. J Biol Chem. 2004. PMID: 15280377 Free article.

10

Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis.

Grant NJ, Coates PJ, Woods YL, Bray SE, Morrice NA, Hastie CJ, Lamont DJ, Carey FA, Sutherland C. Grant NJ, et al. Among authors: woods yl. BMC Cancer. 2015 Nov 10;15:885. doi: 10.1186/s12885-015-1691-1. BMC Cancer. 2015. PMID: 26555036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters